Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg), Tabletten - 100 Swissmedic Key 68472002 Registration Holder Devatis AG Name Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg), Tabletten Date of registration 01.12.2021 Original/Generic Generic Introduction of Sequence 01.12.2021 ATC-Classification Levodopa and Decarboxylase Inhibitor (N04BA02) Revision date WHO WHO-DDD Valid until 30.11.2026 Index Therapeuticus (BSV) 01.08. Show package size 100 Index Therapeuticus (Swissmedic) 01.08. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 5.94 Limitation No Deductible 10 % Consumer price 15.70 Feedback FB Daily cost GTIN 7680684720024 Medication Code Synthetika Pharmacode Disponibility
Composition benserazidum 12.5 mg ut benserazidi hydrochloridum, levodopum 50 mg, natrii docusas, E 172 (rubrum), ethylcellulosum, silica colloidalis anhydrica, cellulosum microcristallinum, amylum pregelificatum, mannitolum, calcii hydrogenophosphas, crospovidonum, magnesii stearas, pro compresso corresp. natrium 0.00259 mg. Packungsbestandteile Galenic Form Tablets Active Agent Dose Benserazide 12.5 mg Levodopa 50 mg
BAG: Active Agent Dose Benserazide 12.5 mg Levodopa 50 mg
Inactive agents additional_information (Rubrum) Amylum Pregelificatum Calcium Hydrogen Phosphate Cellulosum Microcristallinum Crospovidonum E 172 color. Ethylcellulosum Magnesii Stearas Mannitol Natrii Docusas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 06.01.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
